Signals of Change: How Biomarkers Are Reshaping Oncology and Healthcare Delivery
Biomarkers are crucial for confirming diagnoses, predicting disease progression, and tailoring therapeutic modalities, with recent research focusing on genomics, proteomics, and metabolomics.
Cancer remains a leading cause of global mortality, requiring advancements in diagnostic and therapeutic strategies. In modern oncology, cancer biomarkers have become essential for diagnosis and treatment.
Biological molecules such as proteins, genes, or metabolites that indicate the presence, progression, or behavior of cancer
This field is rapidly evolving, driven by cutting-edge platform technologies and innovative ‘multi-omics’ approaches. An editorial published in Cancers provided a review of recent progress in cancer biomarker development.
- Emerging innovations are pushing oncology toward a more proactive approach
- Personalized and economically sound approaches are being explored
Author's summary: Biomarkers reshape oncology and healthcare delivery.
More News
- Conservative Party Overview
- CONSERVATIVE Definition & Meaning
- Behind the scenes of John Rustad's downfall as B.C. Conservative leader
- AIFF Super Cup Final: FC Goa defeats East Bengal on penalties to defend title
- Refused to Livestream Last Gig Ever Later This Month, Launch Kickstarter for a Documentary
- Haven refused to let teenager check in and escorted her off site in growing darkness
- Conservatives | Help us renew
- Super Cup 2025 final: History created as FC Goa retains title after beating East Bengal in penalty shootout
- India lose Junior Hockey World Cup SF; FC Goa win Super Cup; 3 medals for India at ISSF WC Finals
- Scottish Conservative Peer Defects to Reform UK